Equibles does not estimate personal net worth.
Get an email with a short summary when Enanta Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get ENTA alertsThe proxy statement of Enanta Pharmaceuticals Inc reports total compensation of $2,042,356 for Tara L. Kieffer in fiscal 2021, including a base salary of $305,137. Disclosed compensation is on record for 3 fiscal years. Tara L. Kieffer has spoken on 1 investor event across 1 company, most recently for Enanta Pharmaceuticals Inc on September 15, 2026. Enanta Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enanta Pharmaceuticals Inc includes Harry R. Trout, III (CFO), Paul Mellett (CFO), Tara L. Kieffer, Ph.D. (COO) and 5 others.
“We like the mechanism for KIT in terms of looking at mast cell-driven diseases because it It really concerns the underlying mechanism, so by blocking kit, you're actually driving mast cells towards apoptosis, and so there's just less cells available to drive that pathology.”
Proxy statement
Start not stated–present
Last confirmed January 26, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, New Product Strategy & Development | $305,137 | $2,042,356 |
| 2020 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, New Product Strategy & Development | — | — |
| 2019 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, New Product Strategy & Development | — | — |
